100s of titles, one news app for just $10 a month.
Latest Business news:
After $5 Trillion Rout, Emerging Markets Seek Turnaround Signal
The wreckage of a $5 trillion rout in emerging markets is starting to look like a buying opportunity to some…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
New Zealand PM Ardern to visit U.S. to boost exports, lure tourists
New Zealand Prime Minister Jacinda Ardern will visit the United States this week in a bid to boost exports and…
Rod Sims says Facebook should be forced to negotiate with SBS under news media bargaining code
Despite dozens of deals to pay Australian news publishers for content, social media company has left out SBS and the…
Crypto might have an insider trading problem
Anonymous wallets buy up tokens right before they are listed and sell shortly afterward
Airbus Sees Business Jet Sales Boost Despite War, China Lockdown
Airbus SE’s corporate-jet division is more optimistic about prospects for this year, even as the Russia-Ukraine conflict and Chinese coronavirus…
From analysis to good news, read the world’s best news in one place
Why giving your employees a piece of the pie could boost your business
Employee Stock Ownership Plans hold over $1.6tn in assets and can make a more profitable company and a better place…
Global oil firms report huge profits but Indian marketers are left high and dry
Indian oil refiners are staring at huge losses as they have failed to pass on the higher costs of crude…

Zosano Pharma: Q1 Earnings Insights

By Benzinga Insights

Zosano Pharma (NASDAQ:ZSAN) reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75.

Revenue was down $126.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.7 which was followed by a 9.16% drop in the share price the next day.

To track all earnings releases for Zosano Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.